BIOCRYST PHARMACEUTICALS INC (BCRX)
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
BioCryst Presents New Clinical Data and Real-World Evidence Demonstrating Impact of HAE Portfolio at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
PENN Entertainment Celebrates the Official Opening of New Hotel at Hollywood Casino Columbus
Rocket Pharmaceuticals Announces Closing of Sale of Rare Pediatric Disease Priority Review Voucher for $180 Million
QXO Announces Early Tender Results of Cash Tender Offers and Consent Solicitations for Any and All of TopBuild Corp.’s 4.125% Senior Notes due 2032 and 5.625% Senior Notes due 2034 and Receipt of Requisite Consents
Fervo Energy to Report First Quarter 2026 Results on June 22, 2026
Village Farms Launches Pure Sunfarms Pink Kush Cured Resin Vape
Square Financial Services Introduces 3.50% APY High Yield Savings for Square Sellers, More Than 8 Times the National Average
Roots Reports First Quarter Fiscal 2026 Results & Business Update
Invitation Homes Announces Cash Dividend
Ferguson Enterprises Inc. (“Company”): Execution of Rule 10b5-1 Plan